Bumper Offer - Urjas oil Just @ Rs. 1
Rabeglan is a prescription drug, available for use as Injection. It is primarily used for the treatment of Acidity. Other than this, Rabeglan has some other therapeutic uses, which have been discussed ahead.
The right dosage of Rabeglan depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Rabeglan include Diarrhoea. Some other side effects of Rabeglan have been listed ahead. Normally, these side effects of Rabeglan are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Rabeglan's effect during pregnancy is Safe and Moderate while nursing. In addition, Rabeglan's effects on the liver, heart and kidney are discussed below in the Rabeglan related warnings section.
Individuals suffering from medical conditions like Diarrhea (Loose Motions) must refrain from the use of Rabeglan since this can cause severe adverse effects. Other contraindications of Rabeglan have been discussed in the sections ahead.
Drug interactions for Rabeglan have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Rabeglan, it is important to know that it is not safe while driving, and is not habit-forming.
Rabeglan is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Rabeglan is used -
Moderate
Mild
Common
Is the use of Rabeglan safe for pregnant women?
Pregnant women can take Rabeglan without worrying about any side effects.
Is the use of Rabeglan safe during breastfeeding?
Rabeglan can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rabeglan on the Kidneys?
Rabeglan is completely safe for kidneys.
What is the effect of Rabeglan on the Liver?
Side effects of Rabeglan rarely affect the liver.
What is the effect of Rabeglan on the Heart?
Using Rabeglan does not have any harmful effects on the heart.
Rabeglan should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rabeglan unless your doctor advises you to do so -
Is this Rabeglan habit forming or addictive?
Rabeglan is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rabeglan as you may feel sleepy.
Is it safe?
Rabeglan is safe as it does not bear any side effects.
Is it able to treat mental disorders?
No, Rabeglan cannot treat any kind of mental disorder.
Interaction between Food and Rabeglan
Taking Rabeglan with food does not harm your health.
Interaction between Alcohol and Rabeglan
Consult your doctor before consuming alcohol while taking Rabeglan as it can have severe side effects.
This is because a long-term use of Rabeglan can cause Vitamin B12 deficiency. Stomach acids help in the absorption of Vitamin B 12, and this drug suppresses stomach acid which is required for the absorption of vitamin B12. Hence patients taking [medicine] for a long time have Vitamin B12 deficiency. To replenish Vitamin B12 in your body your doctor prescribes this vitamin along with this medicine.
Yes, Rabeglan might lead to low magnesium levels in persons who take it for at least 3 months. Magnesium helps in absorption of vitamin D and calcium, low level of magnesium will affect the absorption of Vit. D and calcium lead to decrease bone density and increases the risk of bone fracture. Low-level magnesium can be managed by taking a dietary supplement which is rich in magnesium.
No, Rabeglan doesn't cause high blood pressure. High blood pressure can be managed by losing some amount of weight, doing some kind of physical activity on a daily basis, eating a healthy diet, reducing sodium in the diet, limiting the amount of alcohol and caffeine, quitting smoking, and taking less stress. If your blood pressure doesn't get controlled, your doctor might start you on a hypertensive drug ( amlodipine, telmisartan etc). Please follow the instructions of your doctor completely.
Yes, Rabeglan is given in combination with domperidone. A fixed-dose combination of [Medicinie] and domperidone is available in the market which is used in the treatment of GERD and other stomach related problems.
No, Rabeglan does not cause kidney damage at recommended doses. However, in case of long-term use of Rabeglan along with improper kidney function, might cause kidney damage. If you experience discoloration of urine ( symptoms of kidney damage) then immediately inform to doctor and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078
